{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:05:34Z","timestamp":1789679134168,"version":"4.0.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1 ZIA AI001222-02"],"award-info":[{"award-number":["1 ZIA AI001222-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jaci.2020.12.633","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T20:00:26Z","timestamp":1612468826000},"page":"428-438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["An appraisal of the Wilson & Jungner criteria in the context of genomic-based newborn screening for inborn errors of immunity"],"prefix":"10.1016","volume":"147","author":[{"given":"Jovanka R.","family":"King","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi D.","family":"Notarangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Hammarstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2020.12.633_bib1","series-title":"The principles and practice of screening for disease","author":"Wilson","year":"1968"},{"key":"10.1016\/j.jaci.2020.12.633_bib2","doi-asserted-by":"crossref","first-page":"E422","DOI":"10.1503\/cmaj.171154","article-title":"Consolidated principles for screening based on a systematic review and consensus process","volume":"190","author":"Dobrow","year":"2018","journal-title":"CMAJ"},{"key":"10.1016\/j.jaci.2020.12.633_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/gim.0b013e31823331d0","article-title":"Revisiting the Wilson-Jungner criteria: how can supplemental criteria guide public health in the era of genetic screening?","volume":"14","author":"Petros","year":"2012","journal-title":"Genet Med"},{"key":"10.1016\/j.jaci.2020.12.633_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2471\/BLT.07.050112","article-title":"Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years","volume":"86","author":"Andermann","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jaci.2020.12.633_bib5","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41436-019-0707-7","article-title":"When should genomic and exome sequencing be implemented in newborns? A\u00a0call for an update to newborn screening guidelines","volume":"22","author":"Hendricks-Sturrup","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.jaci.2020.12.633_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s10875-017-0455-x","article-title":"Newborn screening for primary immunodeficiency diseases: history, current and future practice","volume":"38","author":"King","year":"2018","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib7","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/gim.2017.57","article-title":"Utilization of genomic sequencing for population screening of immunodeficiencies in the newborn","volume":"19","author":"Pavey","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.jaci.2020.12.633_bib8","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41591-020-0966-5","article-title":"The role of exome sequencing in newborn screening for inborn errors of metabolism","volume":"26","author":"Adhikari","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2020.12.633_bib9","first-page":"281","article-title":"Principles and practice of mass screening for disease [in Spanish]","volume":"65","author":"Wilson","year":"1968","journal-title":"Bol Oficina Sanit Panam"},{"key":"10.1016\/j.jaci.2020.12.633_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10875-019-00737-x","article-title":"Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee","volume":"40","author":"Tangye","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib11","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.coi.2017.09.002","article-title":"Pathogenesis of infections in HIV-infected individuals: insights from primary immunodeficiencies","volume":"48","author":"Zhang","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10875-007-9103-1","article-title":"Population prevalence of diagnosed primary immunodeficiency diseases in the United States","volume":"27","author":"Boyle","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib13","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s10875-014-0102-8","article-title":"Prevalence and morbidity of primary immunodeficiency diseases, United States 2001-2007","volume":"34","author":"Kobrynski","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib14","first-page":"212","article-title":"Famili\u00e4rer, angeborener Morbus Werlhofii","volume":"68","author":"Wiskott","year":"1937","journal-title":"Monatsschr Kinderheilkd"},{"key":"10.1016\/j.jaci.2020.12.633_bib15","first-page":"30","article-title":"A propos de l\u2019Epidermodysplasie verruciforme","volume":"92","author":"Lutz","year":"1946","journal-title":"Dermatology"},{"key":"10.1016\/j.jaci.2020.12.633_bib16","first-page":"1","article-title":"Essential lymphocytophthisis: new clinical aspect of infant pathology","volume":"175","author":"Glanzmann","year":"1950","journal-title":"Ann Paediatr"},{"key":"10.1016\/j.jaci.2020.12.633_bib17","first-page":"2861","article-title":"Heredit\u00e4r reticulos: en ny systemsjukdom?","volume":"47","author":"Kostmann","year":"1950","journal-title":"L\u00e4kartidningen"},{"key":"10.1016\/j.jaci.2020.12.633_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1651-2227.1956.tb06875.x","article-title":"Infantile genetic agranulocytosis. A\u00a0new recessive lethal disease in man","volume":"45","author":"Kostmann","year":"1956","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jaci.2020.12.633_bib19","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1542\/peds.9.6.722","volume":"9","author":"Bruton","year":"1952","journal-title":"Agammaglobulinemia. Pediatrics"},{"key":"10.1016\/j.jaci.2020.12.633_bib20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/361226a0","article-title":"The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases","volume":"361","author":"Vetrie","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2020.12.633_bib21","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1182\/blood-2010-08-300384","article-title":"Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening","volume":"117","author":"Brown","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.12.633_bib22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency, 2000-2009","volume":"371","author":"Pai","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.12.633_bib23","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1182\/blood-2018-03-840702","article-title":"SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery","volume":"132","author":"Haddad","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.12.633_bib24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fimmu.2020.00455","article-title":"Newborn screening for presymptomatic diagnosis of complement and phagocyte deficiencies","volume":"11","author":"Dezfouli","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jprot.2015.05.027","article-title":"Heat differentiated complement factor profiling","volume":"126","author":"Hamsten","year":"2015","journal-title":"J Proteomics"},{"key":"10.1016\/j.jaci.2020.12.633_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005321","article-title":"Screening for C3 deficiency in newborns using microarrays","volume":"4","author":"Janzi","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2020.12.633_bib27","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jaci.2014.04.026","article-title":"Combined newborn screening for familial hemophagocytic lymphohistiocytosis and severe T- and B-cell immunodeficiencies","volume":"134","author":"Borte","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/ijns3030019","article-title":"Newborn screening for primary immunodeficiency diseases: the past, the present and the future","volume":"3","author":"King","year":"2017","journal-title":"Int J Neonat Screening"},{"key":"10.1016\/j.jaci.2020.12.633_bib29","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2252","article-title":"Newborn sequencing in genomic medicine and public health","volume":"139","author":"Berg","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2020.12.633_bib30","doi-asserted-by":"crossref","first-page":"336","DOI":"10.5114\/ceji.2017.72825","article-title":"Evaluation of infectious and non-infectious complications in patients with primary immunodeficiency","volume":"42","author":"Bazregari","year":"2017","journal-title":"Cent Eur J Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/pai.12893","article-title":"Kappa-deleting recombination excision circle levels remain low or undetectable throughout life in patients with X-linked agammaglobulinemia","volume":"29","author":"King","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2019.100018","article-title":"X-linked agammaglobulinemia (XLA): phenotype, diagnosis, and therapeutic challenges around the world","volume":"12","author":"El-Sayed","year":"2019","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaci.2020.12.633_bib33","doi-asserted-by":"crossref","first-page":"F1000","DOI":"10.12688\/f1000research.21553.1","article-title":"Recent advances in primary immunodeficiency: from molecular diagnosis to treatment","volume":"9","author":"Bucciol","year":"2020","journal-title":"F1000Res"},{"key":"10.1016\/j.jaci.2020.12.633_bib34","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJM198703053161005","article-title":"Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase","volume":"316","author":"Hershfield","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.12.633_bib35","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/cei.13420","article-title":"Comparison of elapegademase and pegademase in ADA-deficient patients and mice","volume":"200","author":"Murguia-Favela","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib36","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jaci.2018.08.024","article-title":"Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency","volume":"143","author":"Kohn","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib37","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s10875-020-00857-9","article-title":"Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry","volume":"40","author":"Kuo","year":"2020","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib38","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/422993","article-title":"Long-term interferon-gamma therapy for patients with chronic granulomatous disease","volume":"39","author":"Marciano","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2020.12.633_bib39","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.smim.2014.09.008","article-title":"Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-\u03b3 immunity","volume":"26","author":"Bustamante","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib40","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clim.2013.03.016","article-title":"Monogenic autoinflammatory diseases: concept and clinical manifestations","volume":"147","author":"Almeida de Jesus","year":"2013","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib41","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMoa1911326","article-title":"Emapalumab in children with primary hemophagocytic lymphohistiocytosis","volume":"382","author":"Locatelli","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.12.633_bib42","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood.2018894618","article-title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","volume":"133","author":"La Ros\u00e9e","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.12.633_bib43","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.jaci.2018.07.020","article-title":"Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations","volume":"142","author":"Forbes","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib44","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jaci.2014.12.1867","article-title":"Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation","volume":"135","author":"Higgins","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib45","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jaip.2019.02.018","article-title":"Clinical aspects of STAT3 gain-of-function germline mutations: a systematic review","volume":"7","author":"Fabre","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2020.12.633_bib46","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.12.633_bib47","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jpeds.2005.04.017","article-title":"Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome)","volume":"147","author":"Bindl","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaci.2020.12.633_bib48","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10875-008-9196-1","article-title":"Use of sirolimus in IPEX and IPEX-like children","volume":"28","author":"Yong","year":"2008","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib49","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3389\/fimmu.2018.00543","article-title":"Disease evolution and response to rapamycin in activated phosphoinositide 3-kinase \u03b4 syndrome: the European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase \u03b4 Syndrome Registry","volume":"9","author":"Maccari","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2015-07-657981","article-title":"Sirolimus is effective in relapsed\/refractory autoimmune cytopenias: results of a prospective multi-institutional trial","volume":"127","author":"Bride","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.12.633_bib51","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib52","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jaci.2020.12.633_bib53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1056\/NEJMoa1808575","article-title":"Plerixafor for the treatment of WHIM syndrome","volume":"380","author":"McDermott","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.12.633_bib54","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/jpids\/piy114","article-title":"Hematopoietic stem cell transplantation in primary immunodeficiencies beyond severe combined immunodeficiency","volume":"7","author":"Freeman","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.jaci.2020.12.633_bib55","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1182\/blood-2017-09-807487","article-title":"Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency","volume":"131","author":"Fox","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.12.633_bib56","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1089\/hum.2015.137","article-title":"Gene therapy for X-linked severe combined immunodeficiency: where do we stand?","volume":"27","author":"Cavazzana","year":"2016","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jaci.2020.12.633_bib57","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ymthe.2017.12.022","article-title":"Gene therapy for adenosine deaminase deficiency: a comprehensive evaluation of short- and medium-term safety","volume":"26","author":"Cicalese","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/j.jaci.2020.12.633_bib58","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.gendis.2019.07.007","article-title":"Gene therapy and genome editing for primary immunodeficiency diseases","volume":"7","author":"Zhang","year":"2020","journal-title":"Genes Dis"},{"key":"10.1016\/j.jaci.2020.12.633_bib59","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa1815408","article-title":"Lentiviral gene therapy combined with low-dose busulfan in infants with SCID-X1","volume":"380","author":"Mamcarz","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.12.633_bib60","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad8856","article-title":"Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency","volume":"8","author":"De Ravin","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2020.12.633_bib61","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/s41591-019-0676-z","article-title":"Benefit Corporation: a path to affordable gene therapies?","volume":"25","author":"Fischer","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2020.12.633_bib62","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/blood-2010-03-275966","article-title":"Multicenter survey on the outcome of transplantation of hematopoietic cells in patients with the complete form of DiGeorge anomaly","volume":"116","author":"Janda","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.12.633_bib63","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jaci.2017.03.020","article-title":"Thymus transplantation for complete DiGeorge syndrome: European experience","volume":"140","author":"Davies","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib64","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1182\/blood-2012-08-452763","article-title":"GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome","volume":"121","author":"Hsu","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2020.12.633_bib65","doi-asserted-by":"crossref","first-page":"16463","DOI":"10.1073\/pnas.1901409116","article-title":"A deep intronic splice mutation of STAT3 underlies hyper IgE syndrome by negative dominance","volume":"116","author":"Khourieh","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2020.12.633_bib66","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ni.3409","article-title":"DNA polymerase-\u03b1 regulates the activation of type I interferons through cytosolic RNA:DNA synthesis","volume":"17","author":"Starokadomskyy","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib67","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1172\/JCI124011","article-title":"Rescue of recurrent deep intronic mutation underlying cell type-dependent quantitative NEMO deficiency","volume":"129","author":"Boisson","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2020.12.633_bib68","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41525-018-0049-4","article-title":"Rapid whole-genome sequencing decreases infant morbidity and cost of hospitalization","volume":"3","author":"Farnaes","year":"2018","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.jaci.2020.12.633_bib69","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41525-020-00142-z","article-title":"Next-generation sequencing of newborn screening genes: the accuracy of short-read mapping","volume":"5","author":"Trier","year":"2020","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.jaci.2020.12.633_bib70","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2020.12.633_bib71","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20110958","article-title":"Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis","volume":"208","author":"Liu","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2020.12.633_bib72","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/ng1097","article-title":"Impaired response to interferon-alpha\/beta and lethal viral disease in human STAT1 deficiency","volume":"33","author":"Dupuis","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2020.12.633_bib73","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.3389\/fimmu.2018.02078","article-title":"The CBM-opathies\u2014a rapidly expanding spectrum of human inborn errors of immunity caused by mutations in the CARD11-BCL10-MALT1 complex","volume":"9","author":"Lu","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib74","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.3389\/fimmu.2019.02438","article-title":"Dilemma of reporting incidental findings in newborn screening programs for SCID: parents\u2019 perspective on ataxia telangiectasia","volume":"10","author":"Blom","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib75","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.clim.2017.05.007","article-title":"An evaluation of the TREC assay with regard to the integration of SCID screening into the Dutch newborn screening program","volume":"180","author":"Blom","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2020.12.633_bib76","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.3389\/fimmu.2019.02940","article-title":"Ataxia telangiectasia diagnosed on newborn sreening\u2014case cohort of 5 years\u2019 experience","volume":"10","author":"Mandola","year":"2019","journal-title":"Front Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920324222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674920324222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:27:22Z","timestamp":1789676842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674920324222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0091674920324222"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2020.12.633","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An appraisal of the Wilson & Jungner criteria in the context of genomic-based newborn screening for inborn errors of immunity","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2020.12.633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}